Product image of Latanoprost Aspire Pharma (Latanoprost) supplied by GNH India

Latanoprost Aspire Pharma

Active Ingredient:
Latanoprost
Origin:
EU

Latanoprost Aspire Pharma (Latanoprost)

Latanoprost, the active ingredient in Latanoprost Aspire Pharma, is a prostaglandin analog presented as an ophthalmic solution for ocular use. It lowers intra‑ocular pressure and is indicated for open‑angle glaucoma and ocular hypertension in adult patients.

GNH India supplies Latanoprost Aspire Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Aspire Pharma Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Latanoprost is used to manage conditions that involve elevated intra‑ocular pressure within the glaucoma disease family.

  • Open‑angle glaucoma: reduces intra‑ocular pressure to slow optic‑nerve damage and visual field loss.
  • Ocular hypertension: lowers pressure to prevent conversion to glaucoma.
  • Elevated intra‑ocular pressure: maintains target pressure levels to protect the optic nerve.

How It Works

  • Latanoprost binds to prostaglandin F (FP) receptors in the ciliary muscle, promoting remodeling of the extracellular matrix and increasing uveoscleral outflow of aqueous humor. This enhanced outflow lowers intra‑ocular pressure, thereby reducing the risk of optic‑nerve damage associated with glaucoma.

Side Effects

Latanoprost may cause ocular and systemic reactions, most of which are mild and reversible.

Common Side Effects

  • Eye redness: mild conjunctival hyperemia.
  • Increased eyelash growth: longer, thicker lashes.
  • Iris darkening: gradual pigmentation change.
  • Eye irritation: burning or stinging sensation.
  • Blurred vision: temporary visual disturbance.
  • Foreign body sensation: feeling of grit in the eye.

Serious or Rare Side Effects

  • Severe allergic reaction: swelling, rash, or difficulty breathing.
  • Uveitis: inflammation of the uveal tract.
  • Corneal edema: swelling of the cornea affecting clarity.
  • Paradoxical rise in intra‑ocular pressure.
  • Ocular infection: signs of bacterial or fungal involvement.
  • Vision loss: sudden decrease in visual acuity.

Precautions & Warnings

Before initiating therapy, consider the following safety measures.

  • Monitor IOP: regular intra‑ocular pressure checks to assess efficacy.
  • Assess ocular surface: evaluate for pre‑existing inflammation or infection.
  • Pregnancy and lactation: use only if the potential benefit outweighs risk, as safety data are limited.
  • Concomitant eye medications: evaluate for additive ocular effects.
  • Storage: Store at room temperature: keep in the original container, protect from light and moisture.

Avoid Interactions

Latanoprost may interact with other ophthalmic agents, altering efficacy or safety.

Major Interactions (Avoid)

  • Concurrent use with other prostaglandin analogs: may increase risk of ocular irritation.
  • Combination with systemic carbonic anhydrase inhibitors: can lead to excessive IOP reduction.
  • Use with ocular corticosteroids: may diminish steroid efficacy.

Moderate Interactions (Monitor Closely)

  • Nonsteroidal anti‑inflammatory eye drops: may affect prostaglandin pathways.
  • Beta‑blocker eye drops: monitor for additive IOP‑lowering effect.
  • Systemic NSAIDs: potential alteration of prostaglandin metabolism.

Frequently Asked Questions

Latanoprost Aspire Pharma is an ophthalmic solution containing the prostaglandin analog latanoprost. It is prescribed to lower intra‑ocular pressure in adults with open‑angle glaucoma or ocular hypertension, helping to prevent optic‑nerve damage and preserve visual function.

Latanoprost binds to prostaglandin F (FP) receptors in the eye, triggering remodeling of the extracellular matrix in the ciliary body. This process enhances uveoscleral outflow of aqueous humor, thereby reducing intra‑ocular pressure and mitigating the risk of glaucoma progression.

The dosing regimen for Latanoprost Aspire Pharma is determined by the prescribing clinician. Typically, one drop is instilled into the affected eye(s) once daily in the evening, but the exact dose and timing should follow the prescriber’s instructions.

Safety data for latanoprost in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision should be made in consultation with a healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Latanoprost belongs to the prostaglandin analog class, which generally offers once‑daily dosing and strong IOP‑lowering efficacy. Compared with beta‑blocker or carbonic anhydrase inhibitor drops, latanoprost often provides greater pressure reduction with a favorable dosing convenience, though individual response may vary.

Latanoprost Aspire Pharma should be stored at room temperature, ideally below 25 °C. Keep the bottle in its original packaging, protect it from direct light and moisture, and avoid freezing to maintain product stability.

The medication is applied as a single drop into the conjunctival sac of the affected eye(s) once daily, usually in the evening. Patients should wash their hands before use, avoid touching the tip of the bottle to any surface, and close the eye gently after instillation.

Serious risks, though rare, include severe allergic reactions, uveitis, corneal edema, and a paradoxical increase in intra‑ocular pressure. Any sudden eye pain, vision loss, or signs of infection should prompt immediate medical evaluation.

Patients with known hypersensitivity to latanoprost or any component of the formulation should avoid its use. Caution is also advised for individuals with active ocular inflammation, infection, or a history of severe ocular reactions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Latanoprost

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT